Earnings quality
Compare earnings and operating cash flow for earnings quality.
Shionogi & Co., Ltd.
Ticker 4507 · 🇯🇵 Japan · Consolidated IFRS · amounts in yen
Filed 2026-06-19 · Period end 2026-03-31
Takeaway
Dig deeperThe numbers send mixed signals — dig into cash flow and leverage before drawing a conclusion.
equity ratio is 65.4%.
Mixed signals — use cash flow and the balance sheet before treating the year as clean.
ActionDig deeper
OP margin—
Equity ratio65.4%
Last price—
Trailing P/E—
Look at next
- Compare operating cash flow to reported profit across the last two years.
- Open English IR for management commentary on outlook and capital allocation.
- Overlay peers on Compare before judging relative momentum.
About the company
塩野義製薬株式会社 is a Japanese listed company with financial statements filed on EDINET. A detailed English business summary was not auto-extracted from this filing.
Compare trends
No phone/email found in this filing · Filing date 2026-06-19
Financial statements
Income statement
| Account | FY2025 (ended Mar 31, 2025) | FY2026 (ended Mar 31, 2026) |
|---|---|---|
| Revenue | — | — |
| Cost of sales* | — | — |
| Gross profit | ¥374.4B | ¥417.2B |
| Operating profit (loss) | ¥156.6B | ¥166.7B |
| Finance income | ¥53.2B | ¥80.8B |
| Finance costs | ¥9.0B | ¥8.6B |
| Income tax expense | ¥31.2B | ¥33.0B |
| Profit (loss) | ¥169.5B | ¥205.9B |
| Profit (loss) attributable to owners | ¥170.4B | ¥205.2B |
| Basic EPS (¥) | 200.36 | 241.11 |
Balance sheet
| Account | FY2025 (ended Mar 31, 2025) | FY2026 (ended Mar 31, 2026) |
|---|---|---|
| Cash and cash equivalents | ¥374.8B | ¥711.4B |
| Current assets | ¥858.5B | ¥1.3T |
| Non-current assets | ¥676.8B | ¥1.3T |
| Total assets | ¥1.5T | ¥2.6T |
| Short-term borrowings | — | — |
| Current liabilities | ¥129.4B | ¥827.4B |
| Non-current liabilities* | ¥43.5B | ¥63.2B |
| Total liabilities | ¥172.9B | ¥890.7B |
| Equity attributable to owners | ¥1.4T | ¥1.7T |
| Total equity | ¥1.4T | ¥1.7T |
Cash flow statement
| Account | FY2025 (ended Mar 31, 2025) | FY2026 (ended Mar 31, 2026) |
|---|---|---|
| Cash flows from operating activities | ¥195.5B | ¥213.6B |
| Cash flows from investing activities | -¥116.1B | -¥506.1B |
| Cash flows from financing activities | -¥64.9B | ¥599.3B |
| Net increase (decrease) in cash | ¥16.7B | ¥336.6B |
| Cash at end of period | ¥374.8B | ¥711.4B |
Five-year trends
Key metrics
| Metric | Trend | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | ¥335.1B | ¥426.7B | ¥410.1B | ¥438.3B | ¥499.7B | |
| Operating profit | — | — | — | ¥156.6B | ¥166.7B | |
| Profit to owners | ¥114.2B | ¥185.0B | ¥162.0B | ¥170.4B | ¥205.2B | |
| Total assets | ¥1.2T | ¥1.3T | ¥1.4T | ¥1.5T | ¥2.6T | |
| Cash & equivalents | ¥254.4B | ¥309.2B | ¥358.1B | ¥374.8B | ¥711.4B | |
| Owners’ equity | ¥975.7B | ¥1.1T | ¥1.2T | ¥1.4T | ¥1.7T |
How we read these numbers
From the notes
| Item | Amount | Note |
|---|---|---|
| Affiliates stock valuation loss | -¥19.3B | Parent-company special loss (特別損失) |
| Parent special losses (total) | -¥1.5B | Sum of 特別損失 on the parent-company statement |
Mixed
The numbers send mixed signals — dig into cash flow and leverage before drawing a conclusion.
On the income statement, revenue moved from — to — (—), so the top line did not break. Gross profit only slipped from ¥374.4B to ¥417.2B, while operating profit swung from ¥156.6B to ¥166.7B — the damage is concentrated below gross profit.
The notes flag material one-offs this year, including Affiliates stock valuation loss ¥19.3B, Parent special losses (total) ¥1.5B. Treat these as discrete charges when reading the earnings move.
The parent-company income statement also shows material special losses (valuation, spin-off, and affiliate support items).
Operating cash flow was ¥213.6B (prior ¥195.5B), with cash on the balance sheet at ¥711.4B versus ¥374.8B.
The balance sheet got heavier on leverage. Total liabilities rose to ¥890.7B while owners’ equity fell to ¥1.7T. ROE moved from 13.1% to 13.5%, and the equity ratio from 88.7% to 65.4%. Employee count is 6,223 vs 4,955 a year earlier.
Liquidity & leverage
Short-term borrowing levels look more stable year over year.
Capital buffer
Owners’ equity ratio fell from 88.7% to 65.4%; the balance sheet absorbed a heavy loss year.
Was this page helpful?
Source: EDINET S100YF57
(塩野義製薬株式会社), period end 2026-03-31.